Stay updated on Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page
- Check4 days agoChange DetectedOn 2026-05-01, the record history gains a version that includes the Study Status and Contacts/Locations sections, with the 2026-04-30 entry (ID 1012) part of the update. A prior version dated 2026-04-13 was removed from the history.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision label on the page changed from v3.5.2 to v3.5.3, signaling a new release of the page’s history interface. It does not modify any study data or visible elements.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page’s displayed revision/version was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoChange DetectedNew history entries were added for 2026-04-08 to 2026-04-13, including a Study Status update and additional version numbers (1009–1011).SummaryDifference0.0%

- Check33 days agoChange DetectedNew history entries were added documenting updates to Study Status and Contacts/Locations. The updates span from 2026-03-21 to 2026-04-06.SummaryDifference0.2%

- Check49 days agoChange DetectedNew history entries were added for 2026-03-14 through 2026-03-20, including revision v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.